TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal Cupid’s arrival is quickly approaching. Celebrate Read more…
In focus today The US Bureau of Labor Statistics (BLS) announced yesterday that the ongoing partial government shutdown will cause a delay to Friday’s January Jobs Report release. This also affects the annual NFP benchmark Read more…
Monday ended up being a better session for US and European markets than for Asian ones. By the time Europeans came to their desks, the slump in gold and silver prices was largely over. Precious Read more…
RBA lifts cash rate 0.25ppt to 3.85% as expected, citing higher inflation and stronger growth in private sector demand. RBA Monetary Policy Board (MPB) raised the cash rate by 0.25ppts to 3.85% as forecast, citing Read more…
Daily Pivots: (S1) 1.1752; (P) 1.1814; (R1) 1.1851; More…. Intraday bias in EUR/USD remains mildly on the downside at this point. Fall from 1.2081 short term top would target 55 D EMA (now at 1.1721). Read more…
Daily Pivots: (S1) 154.84; (P) 155.32; (R1) 156.08; More… Intraday bias in USD/JPY remains mildly on the upside at this point. Rise from 152.07 is seen as the second leg of the corrective pattern from Read more…
There’s no denying it: Nvidia (NVDA) is priced for perfection. Regardless of your personal opinion, the standard mega-cap argument is no longer valid, with the tech giant now firmly in the perpetual AI capex machine Read more…
The Federal Reserve’s pause on interest-rate cuts in January — and its potential impact on your wallet — was expected by economists and markets. But, in its wake, not everyone agrees it was an appropriate Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Why we love this deal While we’re still in the middle Read more…
Abbott Laboratories’ stock took a direct hit, wiping out nearly 10% of its market value following its Q4 earnings. Response? The CEO bought $2 million shares. Robert B. Ford, CEO of Abbott Laboratories, spent his Read more…